UNIVERSITY OF SOUTHERN CALIFORNIA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 30
- Registration Number
- NCT00183989
- Locations
- 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 20
- Registration Number
- NCT00183794
- Locations
- 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 20
- Registration Number
- NCT00183924
- Locations
- 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States
A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 4
- Registration Number
- NCT00183963
- Locations
- 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States
Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy
Phase 1
Terminated
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 12
- Registration Number
- NCT00183950
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 22
- Registration Number
- NCT00183846
- Locations
- 🇺🇸
U.S.C./Norris Cancer Center, Los Angeles, California, United States
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 42
- Registration Number
- NCT00183859
- Locations
- 🇺🇸
U.S.C. / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 35
- Registration Number
- NCT00183742
- Locations
- 🇺🇸
U.S.C./Norris Comprehensive Cancer Center, Los Angeles, California, United States
Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 25
- Registration Number
- NCT00183911
- Locations
- 🇺🇸
U.S.C. / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 40
- Registration Number
- NCT00183833
- Locations
- 🇺🇸
USC/Norris Cancer Center, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath